SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Titan Pharmaceuticals, Inc. (AMEX: TTP) today announced financial results for the second quarter ended June 30, 2007. Net loss for the second quarter of 2007 was approximately $3.5 million, or $0.08 per share, compared to a net loss of approximately $3.4 million, or $0.09 per share, for the same period last year.
